40 years of methicillin resistant Staphylococcus aureus: MRSA is here to stay—but it can be controlled

BMJ

Volumn 323, Issue 7314, 2001, Pages 644-645

  Van Belkum, Alex ^a   Verbrugh, Henri ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; VACCINE;

ADAPTATION; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; EDITORIAL; EXTRACORPOREAL LITHOTRIPSY; GENETIC RESISTANCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINATION;

CROSS INFECTION; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0035934621     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.323.7314.644     Document Type: Editorial

References (13)

1. Lowy FD. Is Staphylococcus aureus an intracellular pathogen? Trends microbiol 2000; 8: 341–343.
2. Veldkamp KE, Heezius HCJM, Verhoef J, Van Strijp JAG, Van Kessel KPM. Modulation of chemokine receptors by Staphylococcus aureus supernate. Infect Immun 2000; 68: 5908–5913.
3. Sasaki S, Nishikawa S, Miura T, Mizuki M, Yamada K, Madarame H, et al. Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect Immun 2000; 68: 2424–2430.
4. Balaban N, Goldkorn T, Nhan RT, Dang LB, Scott S, Ridgley RM, et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 1998; 280: 438–440.
5. Mazmanian SK, Liu G, Jensen ER, Lenoy E, Schneewind O. Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci USA 2000; 97: 5510–5515.
6. Van Belkum A. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains: state of affairs and tomorrow's possibilities. Micr Drug Resist 2000; 6: 173–188.
7. Wannet WJB, De Neeling AJ, Geubbels ELPE. MRSA in Nederlandse ziekenhuizen: Surveillance resultaten 1998–1999 en toekomstige ontwikkelingen. Infectieziekten Bulletin 2001; 12: 15–18
8. Gorak EJ, Yamada SM, Brown ND. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999; 29: 797–800.
9. Von Eiff C, Overbeck J, Haupt G, Herrmann M, Winckler S, Richter K, et al. Bactericidal effect of extracorporeal shock waves on Staphylococcus aureus. J Med Microbiol 2000; 49: 709–712.
10. Zabner J, Seiler MP, Launspach JL, Karp PH, Kearney WR, Look DC, et al. The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci USA 2000; 97: 11614–11619.
11. Pirisi A. Phage therapy—advantages over antibiotics? Lancet 2000; 356: 1418.
12. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356: 1307–1312.
13. Von Eiff C, Becker K, Machka K, Stammer H, Peters G for the Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344: 11–16.